A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

A Study of Linvoseltamab Alone and Linvoseltamab with Carfilzomib Compared to Standard Treatment in Adults with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Aciclovir
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Ischaemic stroke

Not yet recruiting

Study of Drug Combination with Amodiaquine and Potassium Canrenoate Plus Exenatide or Glibenclamide for Patients with Acute Ischemic Stroke

InvestigationalNo placebo

Study of Drug Combination with Amodiaquine and Potassium Canrenoate Plus Exenatide or Glibenclamide for Patients with Acute Ischemic Stroke

InvestigationalNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Amodiaquine
Sponsor:Genesis Pharma S.A.

Contact Research Centre

Systemic lupus erythematosus+1

Not yet recruiting

A Study of Obecabtagene Autoleucel for Patients with Severe Lupus and Active Kidney Inflammation Not Responding to Standard Treatment

Registered drugNo placebo

A Study of Obecabtagene Autoleucel for Patients with Severe Lupus and Active Kidney Inflammation Not Responding to Standard Treatment

Registered drugNo placebo

Greece

Participants:18–64 years
Substances:Cyclophosphamide
Sponsor:Autolus Limited

Contact Research Centre

Bronchiectasis

Not yet recruiting

Study of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety

Investigational

Study of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Human Normal Immunoglobulin
Sponsor:CSL Behring LLC

Contact Research Centre

Amyotrophic lateral sclerosis

Not yet recruiting

Study on the Effectiveness and Safety of Masitinib with Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

Investigational

Study on the Effectiveness and Safety of Masitinib with Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)

Investigational

Greece

Participants:18–64 years · 65+ years
Substances:Masitinib
Sponsor:Ab Science

Contact Research Centre

Acute myeloid leukaemia

Not yet recruiting

Study on the Safety and Effects of AB8939 and Azacitidine for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Registered drugNo placebo

Study on the Safety and Effects of AB8939 and Azacitidine for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Azacitidine
Sponsor:Ab Science

Contact Research Centre

Non-small cell lung cancer metastatic

Not yet recruiting

Study Comparing Ivonescimab and Chemotherapy with Pembrolizumab and Chemotherapy for Patients with Metastatic Squamous Non-small Cell Lung Cancer

Registered drugNo placebo

Study Comparing Ivonescimab and Chemotherapy with Pembrolizumab and Chemotherapy for Patients with Metastatic Squamous Non-small Cell Lung Cancer

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Summit Therapeutics Inc.

Contact Research Centre

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Anastrozole
Sponsor:Eli Lilly & Co.

Contact Research Centre

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Patras

What the registry says about research in the country

01 Autoimmune Conditions

Innovative research focusing on Sjögren's Syndrome and Systemic Sclerosis, evaluating novel therapeutic approaches with medications like sibeprenlimab and efgartigimod. These trials aim to improve treatment outcomes for patients with chronic autoimmune disorders.

Sjögren's Disease Management
Systemic Sclerosis Treatment
Inflammatory Disease Therapy

Studies are exploring both long-term safety and immediate efficacy of new treatment options.

02 Oncology Research

Comprehensive studies in Multiple Myeloma and advanced cancers, including trials of combination therapies and novel treatments. Research includes investigations into treatments for newly diagnosed and relapsed/refractory cases.

Multiple Myeloma Therapies
Lung Cancer Treatment
Prostate Cancer Management

Focus on improving patient outcomes through targeted and combination therapies.

03 Neurological Disorders

Groundbreaking research in Amyotrophic Lateral Sclerosis and Myasthenia Gravis, evaluating innovative treatments and therapeutic approaches for these challenging neurological conditions.

ALS Treatment Development
Neurological Disease Management
Chronic Neurological Conditions

Studies are examining both disease progression and symptom management.

Back to Greece All countries